AT&T Predicts Future, Save Service with Machine Learning
Release Date: 02/28/2016
Breaking Down AI’s Role in Genomics and Polygenic Risk Prediction - with Dan Elton of the National Human Genome Research Institute
The AI in Business Podcast
Today’s guest is Dan Elton, a Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to the program to explore how AI is advancing genetic research, from protein engineering to gene editing and risk prediction. One of the most significant breakthroughs in this space is AlphaFold, DeepMind’s AI model that predicts protein structures with unprecedented accuracy. While it does not analyze genetic sequences directly, its ability to model protein folding is transforming drug development and protein engineering. Dan also...
info_outline
De-Identified Data and AI Adoption in Healthcare - with Ben Webster of NLP Logix
The AI in Business Podcast
Today’s guest is Ben Webster, VP of AI Solutions at NLP Logix. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. Ben returns to the program to explore the complexities of de-identifying patient data for AI-driven healthcare applications. Hospital chains are increasingly leveraging first-party data assets to ensure compliance while maintaining the analytical power needed for AI models. However, achieving proper de-identification is often costly, time-intensive, and difficult to scale across multiple use cases. This episode is...
info_outline
AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals
The AI in Business Podcast
Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is improving drug development efficiency, addressing data challenges, and overcoming regulatory hurdles. She highlights key breakthroughs like Google DeepMind’s AlphaFold and AI-assisted clinical trial optimization, emphasizing the potential for faster, more cost-effective drug development. The discussion also covers...
info_outline
The Evolving Role of Banks in Fraud Detection and AML Compliance - with Nick Lewis of Standard Chartered Bank
The AI in Business Podcast
Today’s guest is Nick Lewis, Managing Director for the High Risk Client Unit at Standard Chartered Bank. Nick joins today’s show to discuss the shifting landscape of fraud prevention and AML compliance in financial services. As governments increasingly shift regulatory responsibilities onto the private sector, banks find themselves at the forefront of both enforcement and risk management. Lewis highlights how sanctions regimes have evolved, pushing financial institutions to shoulder greater due diligence responsibilities with fewer resources. His conversation with Emerj Editorial Director...
info_outline
Tackling Retail Crime and Loss Prevention with AI Driven Video Security - with Mike Matta of Solink
The AI in Business Podcast
Today’s guest is Mike Matta, Co-founder and CEO of Solink. Solink is a cloud video security and analytics platform that works with your existing cameras, access controls, and operational technologies like POS and labor management, helping you modernize and improve security and operations without costly upgrades. Mike joins today’s show to discuss how AI-driven video data is helping retailers mitigate risk, improve loss prevention strategies, and drive operational efficiencies. Today’s episode is part of a special series on driving video security in retail through data sponsored by...
info_outline
AI and Agentic Systems in Healthcare Workflow Optimization - with Ylan Kazi of Blue Cross Blue Shield of North Dakota
The AI in Business Podcast
Today’s guest is Ylan Kazi, Chief Data and AI Officer at Blue Cross Blue Shield of North Dakota. Ylan returns to the show to discuss the latest developments in AI adoption within healthcare. The conversation explores key obstacles, including cultural resistance, the need for an AI Hippocratic Oath, and the risks of holding AI to unrealistic standards. Ylan also examines how agentic AI—capable of operating across systems to accomplish complex tasks—is reshaping healthcare operations. From optimizing administrative processes to rethinking claims management, AI has the potential to drive...
info_outline
Why Red Teaming is Critical for AI Security - with Tomer Poran of ActiveFence
The AI in Business Podcast
Today’s guest is Tomer Poran, Chief Evangelist and VP of Strategy at ActiveFence. is a leader in providing that mitigate the risk of advanced GenAI systems, helping platforms detect and prevent harmful content, malicious activity, and . Tomer joins today’s podcast to explore the critical role of and security. He breaks down the challenges enterprises face in deploying AI responsibly, the evolving nature of adversarial risks, and why organizations must adopt a proactive approach to testing AI systems. This episode is sponsored by ActiveFence. Learn how...
info_outline
Enhancing Customer Engagement with AI-Driven Solutions - with Robert Rose of Adobe
The AI in Business Podcast
Today’s guest is Robert Rose, Senior Director of North America Customer Support at Adobe. Robert joins our conversation today to discuss the evolution of AI in customer interactions and the challenges organizations face when scaling these solutions across diverse customer bases. He shares insights on how AI-driven bots have progressed from basic transactional tools to more sophisticated systems capable of detecting customer emotions and improving responses over time. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple...
info_outline
Accelerate and Mitigate Risk in Clinical Development - with Panos Karelis of Intelligencia AI
The AI in Business Podcast
Today’s guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today’s show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the “black box” problem in AI and the importance of...
info_outline
Model Development Best Practices for Insurance - with Mark McLaughlin of IBM
The AI in Business Podcast
Today’s guest is Mark McLaughlin, Director of Insurance in IBM’s Global Industries Unit. Mark joins the podcast to discuss the biggest challenges insurers face today and how AI is transforming workflows, risk management, and customer experience. Later, he and Emerj Managing Editor Matthew DeMello explore why insurers are embracing a mix of on-premise and cloud-based strategies, managing multiple AI models to optimize business processes while maintaining security and cost efficiency. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star...
info_outlineWe’ve featured a number of artificial intelligence researchers on the show, but today we switch gears and dive into the business side of the industry. In this episode, Dr. Mazin Gilbert (who earned his PhD in Engineering) breaks down AT&T’s efforts to make more intelligent systems large-scale. How do they train their network to route traffic through the right nodes on holidays, when certain areas of traffic are overloaded? How can a system know, based on signals from hardware, which pieces might be going bad and need replacing and send out a message to alert the company? Making a network ‘aware’ is a large challenge, but Mazin gives an insider’s perspective as to how economic and business pressures are driving AT&T to implement machine learning technologies in order to remain profitable.